Suppr超能文献

碳酸酐酶IV:C末端结构域去除在糖基磷脂酰肌醇锚定及酶活性实现中的作用

Carbonic anhydrase IV: role of removal of C-terminal domain in glycosylphosphatidylinositol anchoring and realization of enzyme activity.

作者信息

Okuyama T, Waheed A, Kusumoto W, Zhu X L, Sly W S

出版信息

Arch Biochem Biophys. 1995 Jul 10;320(2):315-22. doi: 10.1016/0003-9861(95)90015-2.

Abstract

Carbonic anhydrase IV (CA IV) is a glycosylphosphatidylinositol (GPI)-anchored membrane protein expressed on the plasma membrane of specific epithelial and endothelial cells. The human cDNA encodes a 312-amino-acid precursor which includes an NH2-terminal signal sequence (residues -18 to -1) that is removed and a C-terminal hydrophobic domain which is cleaved to permit transfer to the GPI anchor. Using biochemical methods, we established that Ser266 is the site of attachment of the GPI anchor to CA IV from human lung. Based on this result, we constructed missense mutants S266F and G267F and a truncation mutant, G267X, and investigated the role of removal of the C-terminal hydrophobic domain on the synthesis and processing of CA IV in transfected COS cells. The G267F mutation had no effect on CA IV expression. By contrast, the S266F mutation prevented removal of the C-terminal domain and the S266F CA IV was inactive, not GPI-anchored, and not expressed on the cell surface. The G267X C-terminal deletion mutation resulted in secretion of an amount of CA IV severalfold higher than the amounts found in cells transfected with wild type cDNA. These results demonstrate that removal of the C-terminal hydrophobic domain is necessary both for GPI anchoring and for realization of CA IV activity. They further show that bypassing C-terminal processing by deletion of the hydrophobic domain leads to secretion of a fully active CA IV in amounts far greater than those which accumulate in cells expressing the wild type, GPI-anchored CA IV.

摘要

碳酸酐酶IV(CA IV)是一种糖基磷脂酰肌醇(GPI)锚定的膜蛋白,在特定上皮细胞和内皮细胞的质膜上表达。人类cDNA编码一个312个氨基酸的前体,其中包括一个被去除的NH2末端信号序列(-18至-1位残基)和一个C末端疏水结构域,该结构域被切割以允许转移到GPI锚定物上。我们使用生化方法确定,Ser266是人肺CA IV上GPI锚定物的附着位点。基于这一结果,我们构建了错义突变体S266F和G267F以及截短突变体G267X,并研究了去除C末端疏水结构域对转染的COS细胞中CA IV合成和加工的作用。G267F突变对CA IV表达没有影响。相比之下,S266F突变阻止了C末端结构域的去除,并且S266F CA IV无活性,未被GPI锚定,也未在细胞表面表达。G267X C末端缺失突变导致分泌的CA IV量比野生型cDNA转染细胞中的量高出几倍。这些结果表明,去除C末端疏水结构域对于GPI锚定和CA IV活性的实现都是必要的。它们进一步表明,通过缺失疏水结构域绕过C末端加工会导致分泌出完全有活性的CA IV,其数量远远大于表达野生型、GPI锚定的CA IV的细胞中积累的数量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验